Experimental therapies using nanoparticles: nanomaterials in triple-negative breast cancer (TNBC) treatment

1. Howard FM, Olopade OI. Epidemiology of triple-negative breast cancer: a review. Cancer J 2021;27(1):8-16. doi: 10.1097/PPO.0000000000000500.10.1097/PPO.000000000000050033475288 Search in Google Scholar

2. Boyle P. Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 2012;23 Suppl 6:vi7-12. doi: 10.1093/annonc/mds187.10.1093/annonc/mds18723012306 Search in Google Scholar

3. Cho B, Han Y, Lian M, Colditz GA, Weber JD, Ma C, et al. Evaluation of racial/ethnic differences in treatment and mortality among women with triple-negative breast cancer. JAMA Oncol 2021;7(7):1016-23. doi: 10.1001/jamaoncol.2021.1254.10.1001/jamaoncol.2021.1254812044133983438 Search in Google Scholar

4. Gupta GK, Collier AL, Lee D, Hoefer RA, Zheleva V, Siewertsz van Reesema LL, et al. Perspectives on triple-negative breast cancer: current treatment strategies, unmet needs, and potential targets for future therapies. Cancers (Basel) 2020;12(9):2392. doi: 10.3390/cancers12092392.10.3390/cancers12092392756556632846967 Search in Google Scholar

5. Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target 2016;24(3):179-91. doi: 10.3109/1061186X.2015.1051049.10.3109/1061186X.2015.105104926061298 Search in Google Scholar

6. Lungu II, Grumezescu AM, Volceanov A, Andronescu E. Nanobiomaterials used in cancer therapy: an up-to-date overview. Molecules 2019;24(19):3547. doi: 10.3390/molecules24193547.10.3390/molecules24193547680409131574993 Search in Google Scholar

7. Saraiva SM, Gutiérrez-Lovera C, Martínez-Val J, Lores S, Bouzo BL, Díez-Villares S, et al. Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model. Sci Rep 2021;11(1):9873. doi: 10.1038/s41598-021-87968-4.10.1038/s41598-021-87968-4811099533972572 Search in Google Scholar

8. Lasa-Saracíbar B, Aznar MÁ, Lana H, Aizpún I, Gil AG, Blanco-Prieto MJ. Lipid nanoparticles protect from edelfosine toxicity in vivo. Int J Pharm 2014;474(1-2):1-5. doi: 10.1016/j.ijpharm.2014.07.053.10.1016/j.ijpharm.2014.07.05325091376 Search in Google Scholar

9. Luo W, Wang Y. Hypoxia mediates tumor malignancy and therapy resistance. Adv Exp Med Biol 2019;1136:1-18. doi: 10.1007/978-3-030-12734-3_1.10.1007/978-3-030-12734-3_131201713 Search in Google Scholar

10. Cheng FY, Chan CH, Wang BJ, Yeh YL, Wang YJ, Chiu HW. The oxygen-generating calcium peroxide-modified magnetic nanoparticles attenuate hypoxia-induced chemoresistance in triple-negative breast cancer. Cancers (Basel) 2021;13(4):606. doi: 10.3390/cancers13040606.10.3390/cancers13040606791361933546453 Search in Google Scholar

11. Verry C, Porcel E, Chargari C, Rodriguez-Lafrasse C, Balosso J. Utilisation de nanoparticules comme agent radiosensibilisant en radiothérapie: où en est-on? Cancer Radiother 2019;23(8):917-21. doi: 10.1016/j.canrad.2019.07.134.10.1016/j.canrad.2019.07.13431540838 Search in Google Scholar

12. Her S, Jaffray DA, Allen C. Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Adv Drug Deliv Rev 2017;109:84-101. doi: 10.1016/j.addr.2015.12.012.10.1016/j.addr.2015.12.01226712711 Search in Google Scholar

13. Janic B, Brown SL, Neff R, Liu F, Mao G, Chen Y, et al. Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer. Cancer Biol Ther 2021;22(2):124-35. doi: 10.1080/15384047.2020.1861923.10.1080/15384047.2020.1861923792801633459132 Search in Google Scholar

14. Simons M, Raposo G. Exosomes – vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009;21(4):575-81. doi:10.1016/j.ceb.2009.03.007.10.1016/j.ceb.2009.03.00719442504 Search in Google Scholar

15. Zhou X, Xie F, Wang L, Zhang L, Zhang S, Fang M, et al. The function and clinical application of extracellular vesicles in innate immune regulation. Cell Mol Immunol 2020;17(4):323-34. doi: 10.1038/s41423-020-0391-1.10.1038/s41423-020-0391-1710910632203193 Search in Google Scholar

16. Yu M, Gai C, Li Z, Ding D, Zheng J, Zhang W, et al. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Sci 2019;110(10):3173-82. doi: 10.1111/cas.14181.10.1111/cas.14181677863831464035 Search in Google Scholar